News Conference News PCR London Valves 2024 Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes Michael O'Riordan November 26, 2024
News Daily News Knowns and Unknowns in Subclinical Aortic Valve Thrombosis Caitlin E. Cox June 21, 2024
News Conference News NY Valves 2024 Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR Michael O'Riordan June 11, 2024
News Conference News NY Valves 2024 Risk Score IDs Patients Safe for Same-Day Discharge After Low-Risk TAVI Michael O'Riordan June 06, 2024
News Conference News NY Valves 2024 Essentials for 3D-ICE in Structural Interventions Explored in Position Statement Caitlin E. Cox June 06, 2024
News Conference News ESOC 2024 Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60 Todd Neale May 17, 2024
Presentation EuroPCR 2024 Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial Presenter: Patrick Serruys May 15, 2024
News Conference News EuroPCR 2024 Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter? Shelley Wood May 15, 2024
Presentation EuroPCR 2024 Short Methodology Insight - LANDMARK Presenter: Davide Capodanno May 14, 2024
News Conference News THT 2024 Debating the Role of T-TEER in the Sickest Patients Michael O'Riordan March 05, 2024